Resmed (RMD) Revenue by Segment

Breaks down overall revenue into specific business segments, providing insight into which parts of the company are performing well and contributing most to the bottom line.

ResMed’s mix is shifting: the Sleep & Breathing franchise remains the revenue backbone with durable product/resupply momentum, while Residential Care Software is the faster-growing, higher‑margin engine—accelerating after recent M&A and product rollouts. Management’s FY27 guidance strips MatrixCare and flags a suspended Astral ventilator program, so reported growth and near‑term EPS will be modestly depressed even as core revenue and gross‑margin expansion persist. In short, underlying recurring software and mask/device replacement trends are sound, but Astral provisions and the MatrixCare divestiture introduce near‑term noise.